Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.
CompletedOBSERVATIONAL
Enrollment
136
Participants
Timeline
Start Date
December 31, 2013
Primary Completion Date
April 30, 2016
Study Completion Date
April 30, 2016
Conditions
Neovascular Age Related Macular Degeneration
Trial Locations (1)
08820
NJ Retina, Edison
All Listed Sponsors
lead
Prism Vision Group
OTHER
NCT01942213 - Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients. | Biotech Hunter | Biotech Hunter